National Institutes of Health
About National Institutes of Health
National Institutes of Health is a biomedical research facility that focuses on biomedical and health-related research.
Investment focus
Stages
Sectors
Portfolio (13 in our database)
NoomNoom is a psychology-based digital health platform used to provide intelligent nutrition and exercise coaching.Series F · $657M raisedHelixHelix is a population genomics company that is working to advance genomics research and integrate genomic data into clinical care.Series C · $403M raisedEmulateEmulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.Series E · $224M raisedNovaSignalNovaSignal is a medical technology company commercializing a robotic cerebral ultrasound system.Series C · $128M raisedMission BioMission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.Series C · $111M raisedAmerican Gene Technologies InternationalAGT is pioneering gene therapy solutions to achieve permanent cures for human diseases, including a possible cure for HIV in clinical trialsSeries E · $73M raisedNeurotrackNeurotrack develops digital cognitive health solutions to reduce the risk of Alzheimer's and related dementias.Series C · $50M raisedEnvisagenicsEnvisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.Series A · $25M raisedEmocha Healthemocha Health is a digital health company that enables every patient to take every dose with video technology and scalable human engagement.Series A · $15M raisedHealthRhythmsHealthRhythms makes it easy to measure and care for everyone’s mental health.Seed · $13M raisedOligomerixOligomerix develops target identification and validation technologies enhancing the drug discovery process for neurodegenerative diseases.Series B · $12M raisedTalus BioTalus Bio is a drug discovery biotech startup working on drug development for gene regulators.Seed · $10M raisedNovosteoNovosteo, test the efficacy of a new drug to help reduce complications from a broken bone due to a fall.Acquired · $8.0M raised